Transcriptomics

Dataset Information

Cyproheptadine, an epigenetic modifier, exhibits anti-tumor activity by reversing the epigenetic silencing of IRF6 in urothelial carcinoma


ABSTRACT: To investigate the effect of cyproheptadine treatment on bladder cancer cells, expression profile was compared in BFTC905 cells treatment DMSO vs 55µM CPH.

ORGANISM(S): Homo sapiens

PROVIDER: GSE160703 | GEO | 2021/04/08

REPOSITORIES: GEO